PlainPharmaWatch

CMS Open Payments · Program Year 2024

TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc. reported $4,773,750.94 in payments to 2,429 physicians and teaching hospitals across 2,721 transactions.

See the rankings → How this is sourced
$4.8M
Total payments
2,721
Transactions
2,429
Recipients
−$730.1K
General Payments vs PY2023

TriSalus Life Sciences, Inc. reported $4,773,750.94 in payments to 2,429 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #284 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $2.0K per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

TriSalus Life Sciences, Inc. pairs top-quartile payment volume with a broadly spread payment pattern across many recipients.

#284
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
5
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

TriSalus Life Sciences, Inc.'s CMS-reported General Payments decreased by $730.1K (−62.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: TRISALUS LIFE SCIENCES, INC.PY2023: TRISALUS LIFE SCIENCES, INC.PY2024: TriSalus Life Sciences, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.2MPY2024$443.3K
PY2023
$1,173,355.23
PY2024
$443,261.22

How TriSalus Life Sciences, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

TriSalus Life Sciences, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$4,773,751 Top 15% higher than 85% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for TriSalus Life Sciences, Inc.

$4,773,750.94: that is what TriSalus Life Sciences, Inc. reported in payments to 2,429 physicians and teaching hospitals during Program Year 2024, spread across 2,721 transactions ($1.8K per transaction, $2.0K per recipient). The company sits at rank #284 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Consulting Fee" leads the 5-category general-payment breakdown below at $250.1K (5.2% of the company's reported total, 55 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 5 types of general payments, TriSalus Life Sciences, Inc.'s largest category was "Consulting Fee" at $250.1K - 5.2% of the company's reported total.

How TriSalus Life Sciences, Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$250.1K2. Food and Beverage$96.4K3. Honoraria$88.3K4. Travel and Lodging$8.3K5. Compensation for Services…$210.63
Payment Type Amount Transactions
Consulting Fee $250.1K 55
Food and Beverage $96.4K 2,290
Honoraria $88.3K 46
Travel and Lodging $8.3K 31
Compensation for Services Other Than Consulting $210.63 7

Recipient Concentration in General Payments

The five largest recipient relationships account for $166,941.78 (37.7%) of $443,261.22 in this company's General Payments records across 837 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for TriSalus Life Sciences, Inc.

The five named recipients with the highest reported General Payments from this company

James Luethke$46.5KRichard Marshall$36.6KJonathan Joseph Lewis$30.0KDennis Griffin$28.4KRiad Salem$25.5K
  1. 1

    James Luethke

    $46,465.37 across 6 reported transactions

  2. 2

    Richard Marshall

    $36,550.45 across 46 reported transactions

  3. 3

    Jonathan Joseph Lewis

    $30,000.00 across 3 reported transactions

  4. 4

    Dennis Griffin

    $28,441.89 across 8 reported transactions

  5. 5

    Riad Salem

    $25,484.07 across 4 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.8K. Average per recipient: $2.0K.

Total Amount

$4,773,750.94

Avg per Transaction

$1.8K

Avg per Recipient

$2.0K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

TriSalus Life Sciences, Inc. Share

0.0%

#284 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to TriSalus Life Sciences, Inc.

Novocure GmbH

$4.8M 7 recipients

Progenics Pharmaceuticals, Inc.

$4.8M 6,457 recipients

Stemline Therapeutics Inc.

$4.7M 6,314 recipients

Inspire Medical Systems, Inc.

$4.8M 51,283 recipients

InSightec,LTD

$4.9M 2 recipients

Blustone Synergy, LLC

$4.9M 0 recipients

Frequently Asked Questions

How much did TriSalus Life Sciences, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $4,773,750.94 from TriSalus Life Sciences, Inc. to physicians and hospitals across 2,721 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from TriSalus Life Sciences, Inc.? ▾
Averaging $2.0K per recipient, TriSalus Life Sciences, Inc.'s 2024 payments reached 2,429 physicians and teaching hospitals.
What types of payments did TriSalus Life Sciences, Inc. make? ▾
TriSalus Life Sciences, Inc. made 5 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Consulting Fee" at $250.1K, representing 5.2% of the company's reported total.
How does TriSalus Life Sciences, Inc. rank among pharmaceutical companies? ▾
TriSalus Life Sciences, Inc. ranks #284 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from TriSalus Life Sciences, Inc.? ▾
In 2024, TriSalus Life Sciences, Inc. averaged $1.8K per transaction across 2,721 transactions to 2,429 recipients.
Where does the payment data for TriSalus Life Sciences, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download TriSalus Life Sciences, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.